GlaxoSmithKline PLC
NYSE:GSK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
UK |
|
K
|
KB Home
DUS:KBH
|
US |
|
S
|
Samsung Electro-Mechanics Co Ltd
KRX:009155
|
KR |
|
Southstone Minerals Ltd
XTSX:SML
|
CA |
|
R
|
Range Resources Corp
SWB:RAX
|
US |
|
Slater & Gordon Ltd
ASX:SGH
|
AU |
|
Travel + Leisure Co
LSE:0M1K
|
US |
|
D
|
Dongfang Electric Corp Ltd
SWB:DEU
|
CN |
|
A
|
Andlauer Healthcare Group Inc
F:3LT
|
CA |
|
Hindalco Industries Ltd
BSE:500440
|
IN |
|
A
|
Atmos Energy Corp
F:AEO
|
US |
|
B
|
Brinker International Inc
SWB:BKJ
|
US |
|
R
|
Radiant Logistics Inc
AMEX:RLGT
|
US |
|
B
|
B.P. Marsh & Partners PLC
XBER:B5V
|
UK |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
A
|
Air China Ltd
HKEX:753
|
CN |
|
M
|
Manitowoc Company Inc
SWB:MNGN
|
US |
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
IL |
|
York Water Co
NASDAQ:YORW
|
US |
|
M
|
MKS Instruments Inc
F:MKT
|
US |
|
W
|
WEG SA
OTC:WEGZY
|
BR |
|
Japan Excellent Inc
TSE:8987
|
JP |
|
F
|
Future PLC
OTC:FRNWF
|
UK |
|
M
|
Maersk Drilling A/S
F:72D
|
DK |
Wall St Price Targets
GSK Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GSK is 57.08 USD with a low forecast of 39.21 USD and a high forecast of 77.03 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GSK's stock price target?
Price Target
57.08
USD
According to Wall Street analysts, the average 1-year price target for GSK is 57.08 USD with a low forecast of 39.21 USD and a high forecast of 77.03 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.
